Back to top
more

Becton, Dickinson and Company (BDX)

(Delayed Data from NYSE)

$236.34 USD

236.34
2,258,170

-5.84 (-2.41%)

Updated Sep 4, 2024 04:00 PM ET

After-Market: $236.50 +0.16 (0.07%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 32% (170 out of 251)

Industry: Medical - Dental Supplies

Better trading starts here.

Zacks News

Based in Franklin Lakes, NJ, Becton, Dickinson and Company (BDX) commonly known as BD, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. In fiscal 2019, BD’s revenues increased 8.2% to $17.29 billion. Earlier, BD’s operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. However, the company’s organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional.

Three Reasons to Retain BD (BDX) Stock in Your Portfolio Now

BD's (BDX) robust product portfolio raises optimism about the stock.

BD's (BDX) FDA-Approved Test to Offer Wider Testing Access

BD's (BDX) receipt of the FDA's clearance for the use of self-collected vaginal specimens for HPV testing is likely to improve screening access to a wider female population.

Stock Market News for May 3, 2024

U.S. stock markets closed sharply higher on Thursday.

Here's Why Becton Dickinson (BDX) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Compared to Estimates, Becton Dickinson (BDX) Q2 Earnings: A Look at Key Metrics

The headline numbers for Becton Dickinson (BDX) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

BD (BDX) Q2 Earnings Surpass Estimates, FY24 View Revised

BD's (BDX) overall top line benefits from revenue growth in all segments and both geographic regions in the fiscal second quarter.

Becton Dickinson (BDX) Surpasses Q2 Earnings and Revenue Estimates

Becton Dickinson (BDX) delivered earnings and revenue surprises of 7.09% and 0.30%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

What's in Store for These 5 Medical Device Stocks in Q1 Earnings?

Here is a sneak peek into how five medical device stocks, BDX, BAX, XRAY, CAH and DVA, might fare in their quarterly results slated to be released tomorrow.

Here's Why You Should Hold Lantheus (LNTH) in Your Portfolio Now

Lantheus' (LNTH) focus on pipeline development raises optimism about the stock.

GE HealthCare (GEHC) Q1 Earnings In Line, Sales Volume Decline

GE HealthCare's (GEHC) first-quarter results witness declining segmental revenues in imaging, ultrasound and patient care. The bottom line improves on better pricing.

Sustained Product Demand Likely to Aid BD's (BDX) Q2 Earnings

Continued solid uptake of BD's (BDX) products is expected to have driven fiscal second-quarter revenues.

Revvity (RVTY) Q1 Earnings and Revenues Surpass Estimates

Revvity's (RVTY) first-quarter results showcase a decline in life sciences segmental revenues. However, the company's earnings and revenues beat their respective estimates.

Bruker's (BRKR) Balanced Segmental Growth, Innovation Aid

Bruker (BRKR) revenues continue to be driven by the strength of end markets, including academic, government and industrial.

Unveiling Becton Dickinson (BDX) Q2 Outlook: Wall Street Estimates for Key Metrics

Get a deeper insight into the potential performance of Becton Dickinson (BDX) for the quarter ended March 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Philips (PHG) Receives FDA Warning Letter Regarding CT Systems

Philips (PHG) receives a warning letter from the FDA in respect of a manufacturing plant in China regarding faults in the manufacturing of CT systems.

DexCom (DXCM) Q1 Earnings Beat, Strong CGM Demand Continues

DexCom's (DXCM) first-quarter 2024 results reflect strong domestic and international revenue growth on the back of its real-time Continuous Glucose Monitoring system.

Revvity's (RVTY) New Launch to Boost Tuberculosis Testing

Revvity's (RVTY) latest offering is likely to provide a new and improved workflow to lower hands-on time and enable increased lab productivity.

CONMED (CNMD) Q1 Earnings & Revenues Surpass Estimates

CONMED's (CNMD) adjusted first-quarter earnings and revenues beat estimates on the back of strong U.S. and International markets as well as supply-chain improvement.

Veeva's (VEEV) AI Partner Program to Develop GenAI Solutions

Veeva (VEEV) announces the Veeva AI Partner Program, which is expected to provide partners assistance to combine Generative AI solutions with Veeva Vault applications.

West Pharmaceutical (WST) Q1 Earnings Beat, HVP Sales Weak

West Pharmaceutical's (WST) first-quarter results reflect a strong demand for non-COVID-19 products, especially HVP devices.

Penumbra's (PEN) New Launch to Enhance Blood Clot Removal

Penumbra's (PEN) latest offering is likely to enable physicians to restore blood flow more quickly and further minimize blood loss.

Reasons Why You Should Retain HealthEquity (HQY) Stock for Now

HealthEquity's (HQY) sustained strength in HSAs raises optimism about the stock.

GE HealthCare's (GEHC) New Tie-Up to Boost Patient Outcomes

GE HealthCare's (GEHC) latest partnership is likely to benefit global healthcare systems by enhancing Elekta's RT offerings with its MIM Software medical imaging management solutions.

Nalak Das headshot

Top 5 U.S. Giants at Lucrative Valuations Amid April Turmoil

We have narrowed our search to five U.S. bigwigs (market capital > $70 billion) with attractive valuations. These are: NVDA, MU, BDX, ANET, EQIX.

BDX or MMSI: Which Is the Better Value Stock Right Now?

BDX vs. MMSI: Which Stock Is the Better Value Option?